Circulating interferon–α and soluble CD25 are associated with distinct pulmonary phenotypes in untreated early rheumatoid arthritis
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Pulmonary abnormalities (PA) of airways and parenchyma are prevalent in rheumatoid arthritis (RA), and interstitial lung disease (ILD) is a severe extra-articular manifestation affecting up to 10% of patients. Yet, the immune mechanisms underlying the different forms of pulmonary involvement and the relationships between them remain incompletely understood. We investigated whether distinct pulmonary phenotypes in untreated patients with newly diagnosed RA are associated with specific systemic immune profiles. Methods This cross-sectional study included 55 consecutive treatment-naïve patients with newly diagnosed autoantibody-positive RA who underwent high-resolution computed tomography of the lungs. Presence of bronchiectasis, bronchial wall thickening, air trapping, reticulations, ground-glass opacities, traction bronchiectasis, honeycombing, pleural effusion and parenchymal nodules was evaluated by thoracic radiologists in consensus. Serum cytokines, chemokines and growth factors were quantified using a 48-plex immunoassay, neutrophil elastase by ELISA, and interferon α (IFN–α) by Single molecule array (Simoa) ultra-sensitive immunoassay. A type I interferon gene score was determined by RT-PCR based on the mean gene expression of IFI6 , IFI44L , ISG15 , MX1 and OAS1 . Multivariate data analyses were followed by predefined univariate validation of the five highest-ranked variables associated with 1) parenchymal nodules, 2) interstitial lung abnormalities (ILA) and 3) airway abnormalities. Sensitivity analyses and correlations with clinical parameters were performed. Results Pulmonary abnormalities were identified in 78% of the untreated early (ue) RA patients. Despite substantial overlap between the pulmonary phenotypes, both airway abnormalities and parenchymal nodules were present as isolated phenotypes. A presence of any PA was strongly associated with rheumatoid factor IgM and systemic inflammation. Higher levels of soluble CD25 were associated with parenchymal nodules, whereas ILA was associated with increased IFN–α levels and higher Disease Activity Score in 28 joints. The most significant markers of airway abnormalities were increased CRP and shorter symptom duration. Conclusions Pulmonary phenotypes in ueRA are associated with different inflammatory and immune activation profiles and suggest IFN–α as a candidate biomarker for ILD development. Whether the lungs represent a primary site of autoimmune events during the development of RA or an extra-articular site of RA-related inflammation remains to be determined.
Source: Research Square
Institutions: University of Gothenburg, Skaraborg Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rheumatoid arthritis, pulmonary involvement, interstitial lung disease, interferon-alpha, soluble interleukin-2 receptor, type I interferon, airway abnormalities, bronchiectasis, air trapping, IgM rheumatoid factor, systemic inflammation, biomarkers, early rheumatoid arthritis, untreated patients, disease activity, C-reactive protein, symptom duration
Open Access status: green
Funders: Västra Götalandsregionen, Rune och Ulla Amlövs Stiftelse för Neurologisk och Reumatologisk Forskning, European Commission, Vetenskapsrådet, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Reumatikerförbundet, Stiftelsen Mary von Sydows, född Wijk, donationsfond, HORIZON EUROPE Framework Programme
Awards: Fluid biomarkers for neurodegenerative dementias, G4260843567, Fluid biomarkers for neurodegenerative dementias, CASCADE: CAuSe or Consequence in Alzheimer DiseasE?, G6158734006, G6422975485, Effects of tofacitinib vs methotrexate on clinical and molecular disease activity markers in joints and lungs in early rheumatoid arthritis (PULMORA)
OpenAlex ID: W7226023539
